Public signalCompany raiseAuto-indexed · Unverified
DermBiont, Inc. raised $32.7M
DermBiont, Inc.· BOSTON, US· Biotechnology· Filed Nov 13, 2024
DermBiont, Inc. reported raising capital. Based in BOSTON, MASSACHUSETTS, US. First sale reported 2023-10-04. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$32.7M
Confidence90%
Raised
$32.7M
Investors
72
Jurisdiction
DELAWARE
On the record
- Location
- BOSTON, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $32.7M
- Target amount
- $45.3M
- Filing date
- Nov 13, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 72
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $45.3M
- Amendment
- Yes
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 32,697,081 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Nov 13, 2024. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with DermBiont, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record